pentobarbital decreases levels of panobinostat by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Contraindicated. Strong CYP3A4 inducers can minimize panobinostat degrees by ~70% and produce remedy failure. pentobarbital will reduce the level or influence of osilodrostat by affecting hepa